MetaADEDB 2.0 @ LMMD
Sertraline
(BLFQGGGGFNSJKA-XHXSRVRCSA-N)
Structure
SMILES
CN[C@H]1CC[C@H](c2c1cccc2)c1ccc(c(c1)Cl)Cl.Cl
Molecular Formula:
C17H18Cl3N
Molecular Weight:
342.691
Log P:
6.3725
Hydrogen Bond Acceptor:
1
Hydrogen Bond Donor:
2
TPSA:
12.03
CAS Number(s):
79559-97-0; 79617-95-1
Synonym(s)
1.
Sertraline
2.
Altruline
3.
Apo-Sertraline
4.
Aremis
5.
Besitran
6.
Gen-Sertraline
7.
Gladem
8.
Lustral
9.
Novo-Sertraline
10.
Rhoxal-sertraline
11.
Sealdin
12.
Sertraline Hydrochloride
13.
Sertraline Hydrochloride (1S-cis)-Isomer
14.
Zoloft
15.
ratio-Sertraline
16.
Apo Sertraline
17.
Gen Sertraline
18.
Hydrochloride, Sertraline
19.
Novo Sertraline
20.
Rhoxal sertraline
21.
ratio Sertraline
External Link(s)
MeSHD020280
PubChem Compound11078406
63009
50986904
ChEBI9124
CHEMBLCHEMBL1709
KEGGdr:D00825
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 1367
Canada Vigilance: 41
Canada Vigilance
US FAERS
2AnxietyFAERS: 796
Canada Vigilance: 17
Canada Vigilance
US FAERS
3Drug exposure during pregnancyFAERS: 566US FAERS
4FatigueFAERS: 559
Canada Vigilance: 5
Canada Vigilance
US FAERS
5Feeling abnormalFAERS: 526
Canada Vigilance: 3
Canada Vigilance
US FAERS
6HeadacheFAERS: 495
Canada Vigilance: 11
Canada Vigilance
US FAERS
7NauseaFAERS: 471
Canada Vigilance: 15
Canada Vigilance
US FAERS
8DizzinessFAERS: 463
Canada Vigilance: 20
Canada Vigilance
US FAERS
9Maternal exposure during pregnancyFAERS: 458US FAERS
10AstheniaFAERS: 364
Canada Vigilance: 2
Canada Vigilance
US FAERS
11Maternal exposure timing unspecifiedFAERS: 355US FAERS
12TremorFAERS: 344
Canada Vigilance: 9
Canada Vigilance
US FAERS
13MalaiseFAERS: 312
Canada Vigilance: 6
Canada Vigilance
US FAERS
14CryingFAERS: 297
Canada Vigilance: 1
Canada Vigilance
US FAERS
15NervousnessFAERS: 287
Canada Vigilance: 3
Canada Vigilance
US FAERS
16ApathyFAERS: 286US FAERS
17Depressed moodFAERS: 272
Canada Vigilance: 1
Canada Vigilance
US FAERS
18AgitationFAERS: 256
Canada Vigilance: 10
Canada Vigilance
US FAERS
19Drug withdrawal syndromeFAERS: 241
Canada Vigilance: 1
Canada Vigilance
US FAERS
20RestlessnessFAERS: 233US FAERS
21Abdominal discomfortFAERS: 222
Canada Vigilance: 6
Canada Vigilance
US FAERS
22PainFAERS: 222
Canada Vigilance: 4
Canada Vigilance
US FAERS
23Completed SuicideFAERS: 217
Canada Vigilance: 11
Canada Vigilance
US FAERS
24MyalgiaFAERS: 215
Canada Vigilance: 3
Canada Vigilance
US FAERS
25PalpitationsFAERS: 214
Canada Vigilance: 4
Canada Vigilance
US FAERS
26VomitingFAERS: 214
Canada Vigilance: 5
Canada Vigilance
US FAERS
27Suicide attemptFAERS: 204
Canada Vigilance: 10
Canada Vigilance
US FAERS
28TensionFAERS: 191US FAERS
29Psychiatric symptomFAERS: 176US FAERS
30AngerFAERS: 167
Canada Vigilance: 4
Canada Vigilance
US FAERS
31Feelings of worthlessnessFAERS: 162US FAERS
32SomnolenceFAERS: 146
Canada Vigilance: 2
Canada Vigilance
US FAERS
33Negative thoughtsFAERS: 141US FAERS
34Patent ductus arteriosusFAERS: 140US FAERS
35Product substitution issueFAERS: 128
Canada Vigilance: 3
Canada Vigilance
US FAERS
36AlopeciaFAERS: 124
Canada Vigilance: 1
Canada Vigilance
US FAERS
37Drug DependenceFAERS: 115
Canada Vigilance: 1
Canada Vigilance
US FAERS
38Weight decreasedFAERS: 115
Canada Vigilance: 2
Canada Vigilance
US FAERS
39OverdoseFAERS: 108
Canada Vigilance: 1
Canada Vigilance
US FAERS
40AmnesiaFAERS: 97
Canada Vigilance: 3
Canada Vigilance
US FAERS
41Emotional disorderFAERS: 97
Canada Vigilance: 1
Canada Vigilance
US FAERS
42PruritusFAERS: 95
Canada Vigilance: 3
Canada Vigilance
US FAERS
43CardiomegalyFAERS: 94US FAERS
44Pharmaceutical product complaintFAERS: 92US FAERS
45Obsessive-Compulsive DisorderFAERS: 84
Canada Vigilance: 2
Canada Vigilance
US FAERS
46TinnitusFAERS: 84
Canada Vigilance: 5
Canada Vigilance
US FAERS
47HypersensitivityFAERS: 82
Canada Vigilance: 2
Canada Vigilance
US FAERS
48Serotonin SyndromeFAERS: 81
Canada Vigilance: 10
Canada Vigilance
US FAERS
49Memory impairmentFAERS: 79
Canada Vigilance: 3
Canada Vigilance
US FAERS
50ConstipationFAERS: 77
Canada Vigilance: 3
Canada Vigilance
US FAERS
51Cleft PalateFAERS: 75US FAERS
52Activities of daily living impairedFAERS: 73US FAERS
53Drug effect incompleteFAERS: 73US FAERS
54Sexual DysfunctionFAERS: 70
Canada Vigilance: 3
Canada Vigilance
US FAERS
55Visual ImpairmentFAERS: 70
Canada Vigilance: 3
Canada Vigilance
US FAERS
56Cerebrovascular accidentFAERS: 69US FAERS
57Chest PainFAERS: 68
Canada Vigilance: 4
Canada Vigilance
US FAERS
58Mood swingsFAERS: 67
Canada Vigilance: 2
Canada Vigilance
US FAERS
59TalipesFAERS: 67US FAERS
60CraniosynostosisFAERS: 65US FAERS
61Pulmonary Valve StenosisFAERS: 65US FAERS
62Respiratory distressFAERS: 63
Canada Vigilance: 1
Canada Vigilance
US FAERS
63UrticariaFAERS: 62
Canada Vigilance: 1
Canada Vigilance
US FAERS
64Therapeutic response unexpected with drug substitutionFAERS: 61US FAERS
65Drug screen false positiveFAERS: 60US FAERS
66DysgeusiaFAERS: 60US FAERS
67ParanoiaFAERS: 60
Canada Vigilance: 3
Canada Vigilance
US FAERS
68Personality ChangeFAERS: 60US FAERS
69StressFAERS: 60
Canada Vigilance: 1
Canada Vigilance
US FAERS
70ArthralgiaFAERS: 59
Canada Vigilance: 1
Canada Vigilance
US FAERS
71CyanosisFAERS: 59US FAERS
72Abdominal PainFAERS: 58
Canada Vigilance: 3
Canada Vigilance
US FAERS
73Feeling jitteryFAERS: 58
Canada Vigilance: 1
Canada Vigilance
US FAERS
74DyspepsiaFAERS: 57
Canada Vigilance: 2
Canada Vigilance
US FAERS
75Myocardial InfarctionFAERS: 57US FAERS
76VertigoFAERS: 56US FAERS
77Impaired work abilityFAERS: 53US FAERS
78LethargyFAERS: 53
Canada Vigilance: 2
Canada Vigilance
US FAERS
79Pulmonary HypertensionFAERS: 53
Canada Vigilance: 1
Canada Vigilance
US FAERS
80Intentional self-injuryFAERS: 52
Canada Vigilance: 3
Canada Vigilance
US FAERS
81BruxismFAERS: 51US FAERS
82DisorientationFAERS: 51
Canada Vigilance: 2
Canada Vigilance
US FAERS
83PneumoniaFAERS: 51US FAERS
84AsthmaFAERS: 49US FAERS
85Erectile dysfunctionFAERS: 47
Canada Vigilance: 1
Canada Vigilance
US FAERS
86Night sweatsFAERS: 46US FAERS
87SyncopeFAERS: 46
Canada Vigilance: 2
Canada Vigilance
US FAERS
88nervous system disorderFAERS: 46US FAERS
89Blood cholesterol increasedFAERS: 45US FAERS
90MydriasisFAERS: 45
Canada Vigilance: 1
Canada Vigilance
US FAERS
91PregnancyFAERS: 45US FAERS
92TachycardiaFAERS: 45
Canada Vigilance: 2
Canada Vigilance
US FAERS
93Toxicity to various agentsFAERS: 44
Canada Vigilance: 1
Canada Vigilance
US FAERS
94StillbirthFAERS: 43US FAERS
95Failure to ThriveFAERS: 42US FAERS
96Incorrect dose administeredFAERS: 41US FAERS
97Unevaluable eventFAERS: 41US FAERS
98AkathisiaFAERS: 40US FAERS
99DiscomfortFAERS: 40US FAERS
100Disease recurrenceFAERS: 40US FAERS
101HypotensionFAERS: 40
Canada Vigilance: 3
Canada Vigilance
US FAERS
102Therapeutic response unexpectedFAERS: 40
Canada Vigilance: 1
Canada Vigilance
US FAERS
103DeafnessFAERS: 38US FAERS
104Intentional product misuseFAERS: 38US FAERS
105Mental impairmentFAERS: 38US FAERS
106Cardiac ArrestFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
107Product quality issueFAERS: 36US FAERS
108Bipolar DisorderFAERS: 35US FAERS
109Otitis MediaFAERS: 35US FAERS
110Urinary tract infectionFAERS: 35US FAERS
111Back PainFAERS: 34US FAERS
112EpilepsyFAERS: 34US FAERS
113No adverse eventFAERS: 34US FAERS
114Product use issueFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
115Blood creatine phosphokinase increasedFAERS: 33US FAERS
116Chest discomfortFAERS: 33
Canada Vigilance: 2
Canada Vigilance
US FAERS
117ChillsFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
118DehydrationFAERS: 33US FAERS
119Drug dose omissionFAERS: 33US FAERS
120Drug screen positiveFAERS: 33US FAERS
121DysarthriaFAERS: 33US FAERS
122Eye painFAERS: 33
Canada Vigilance: 2
Canada Vigilance
US FAERS
123Musculoskeletal stiffnessFAERS: 33
Canada Vigilance: 1
Canada Vigilance
US FAERS
124Throat irritationFAERS: 33
Canada Vigilance: 2
Canada Vigilance
US FAERS
125Drug exposure via breast milkFAERS: 32US FAERS
126HostilityFAERS: 32
Canada Vigilance: 1
Canada Vigilance
US FAERS
127Product use in unapproved indicationFAERS: 32
Canada Vigilance: 2
Canada Vigilance
US FAERS
128ErythemaFAERS: 31
Canada Vigilance: 1
Canada Vigilance
US FAERS
129InfluenzaFAERS: 31US FAERS
130Medication ErrorFAERS: 31US FAERS
131Restless Legs SyndromeFAERS: 31US FAERS
132Burning sensationFAERS: 30
Canada Vigilance: 3
Canada Vigilance
US FAERS
133Feeding disorder neonatalFAERS: 30US FAERS
134HypersomniaFAERS: 30
Canada Vigilance: 1
Canada Vigilance
US FAERS
135Respiratory FailureFAERS: 30US FAERS
136StrabismusFAERS: 30US FAERS
137jaundiceFAERS: 30US FAERS
138AnorgasmiaFAERS: 29
Canada Vigilance: 3
Canada Vigilance
US FAERS
139DissociationFAERS: 29US FAERS
140FibromyalgiaFAERS: 28US FAERS
141PhotophobiaFAERS: 28
Canada Vigilance: 1
Canada Vigilance
US FAERS
142PsoriasisFAERS: 28US FAERS
143Right Ventricular HypertrophyFAERS: 28US FAERS
144Diabetes MellitusFAERS: 27
Canada Vigilance: 1
Canada Vigilance
US FAERS
145EpistaxisFAERS: 27US FAERS
146HomicideFAERS: 27US FAERS
147HypothyroidismFAERS: 27US FAERS
148Wrong technique in drug usage processFAERS: 27US FAERS
149BlindnessFAERS: 25
Canada Vigilance: 2
Canada Vigilance
US FAERS
150Drug ineffective for unapproved indicationFAERS: 25US FAERS
151AnorexiaFAERS: 24US FAERS
152Emotional distressFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
153Hypoplastic Left Heart SyndromeFAERS: 24US FAERS
154NasopharyngitisFAERS: 24US FAERS
155Neonatal disorderFAERS: 24US FAERS
156RhabdomyolysisFAERS: 24
Canada Vigilance: 1
Canada Vigilance
US FAERS
157DysphoniaFAERS: 23US FAERS
158Lip swellingFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
159Respiratory arrestFAERS: 23US FAERS
160TorticollisFAERS: 23US FAERS
161Urinary RetentionFAERS: 23
Canada Vigilance: 2
Canada Vigilance
US FAERS
162ArthritisFAERS: 22US FAERS
163Dental cariesFAERS: 22US FAERS
164Physical assaultFAERS: 22US FAERS
165AsphyxiaFAERS: 21US FAERS
166DementiaFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
167Drug abuseFAERS: 21US FAERS
168Drug toxicityFAERS: 21US FAERS
169Pre-existing condition improvedFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
170Blood sodium decreasedFAERS: 20US FAERS
171Flat affectFAERS: 20US FAERS
172Muscle tightnessFAERS: 20US FAERS
173Visual disturbanceFAERS: 20US FAERS
174Cold sweatFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
175Economic problemFAERS: 19US FAERS
176InfectionFAERS: 19US FAERS
177Middle insomniaFAERS: 19US FAERS
178Quality of life decreasedFAERS: 19
Canada Vigilance: 2
Canada Vigilance
US FAERS
179Spina BifidaFAERS: 19US FAERS
180Urinary IncontinenceFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
181Alanine Aminotransferase IncreasedFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
182AtelectasisFAERS: 18US FAERS
183CholestasisFAERS: 18US FAERS
184Double Outlet Right VentricleFAERS: 18US FAERS
185Duodenal ulcer perforationFAERS: 18US FAERS
186DysuriaFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
187Euphoric moodFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
188MyoclonusFAERS: 18US FAERS
189Product taste abnormalFAERS: 18US FAERS
190ArthropathyFAERS: 17US FAERS
191Aspartate Aminotransferase IncreasedFAERS: 17US FAERS
192BedriddenFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
193Blood glucose increasedFAERS: 17US FAERS
194ChromaturiaFAERS: 17US FAERS
195Drug dispensing errorFAERS: 17US FAERS
196Exposure during breast feedingFAERS: 17US FAERS
197Feeling ColdFAERS: 17US FAERS
198Fine motor delayFAERS: 17US FAERS
199General physical health deteriorationFAERS: 17US FAERS
200Neck PainFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
201Oropharyngeal painFAERS: 17US FAERS
202Poor quality sleepFAERS: 17US FAERS
203Post procedural complicationFAERS: 17US FAERS
204SinusitisFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
205TrismusFAERS: 17US FAERS
206Wrong technique in product usage processFAERS: 17
Canada Vigilance: 2
Canada Vigilance
US FAERS
207Accidental overdoseFAERS: 16US FAERS
208Adverse eventFAERS: 16US FAERS
209AmblyopiaFAERS: 16US FAERS
210Head discomfortFAERS: 16
Canada Vigilance: 2
Canada Vigilance
US FAERS
211HypospadiasFAERS: 16US FAERS
212Impaired driving abilityFAERS: 16US FAERS
213Intentional drug misuseFAERS: 16US FAERS
214Joint swellingFAERS: 16US FAERS
215Obsessive thoughtsFAERS: 16US FAERS
216Panic DisorderFAERS: 16US FAERS
217RetchingFAERS: 16US FAERS
218SepsisFAERS: 16US FAERS
219Sinus TachycardiaFAERS: 16US FAERS
220SwellingFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
221AcneFAERS: 15US FAERS
222Altered state of consciousnessFAERS: 15US FAERS
223BronchitisFAERS: 15US FAERS
224DisabilityFAERS: 15US FAERS
225DysgraphiaFAERS: 15US FAERS
226EczemaFAERS: 15US FAERS
227Electrocardiogram abnormalFAERS: 15US FAERS
228FlatulenceFAERS: 15
Canada Vigilance: 2
Canada Vigilance
US FAERS
229FormicationFAERS: 15US FAERS
230FractureFAERS: 15US FAERS
231HydrocephalusFAERS: 15US FAERS
232HypomaniaFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
233Mixed receptive-expressive language disorderFAERS: 15US FAERS
234Muscle RigidityFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
235Post-Traumatic Stress DisorderFAERS: 15US FAERS
236ScreamingFAERS: 15US FAERS
237ThrombocytopeniaFAERS: 15
Canada Vigilance: 1
Canada Vigilance
US FAERS
238Bicuspid aortic valveFAERS: 14US FAERS
239Bronchopulmonary DysplasiaFAERS: 14US FAERS
240DeliriumFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
241DystoniaFAERS: 14US FAERS
242Head deformityFAERS: 14US FAERS
243Mental status changesFAERS: 14US FAERS
244Mild Mental RetardationFAERS: 14US FAERS
245MurderFAERS: 14US FAERS
246Perinatal brain damageFAERS: 14US FAERS
247Right atrial dilatationFAERS: 14US FAERS
248TachyphreniaFAERS: 14US FAERS
249Wound InfectionFAERS: 14US FAERS
250AnhedoniaFAERS: 13US FAERS
251AphasiaFAERS: 13US FAERS
252Bipolar I disorderFAERS: 13US FAERS
253Cerebral disorderFAERS: 13US FAERS
254DependenceFAERS: 13US FAERS
255Depressed Level of ConsciousnessFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
256Dry skinFAERS: 13US FAERS
257FlushingFAERS: 13US FAERS
258FrustrationFAERS: 13US FAERS
259HyperreflexiaFAERS: 13US FAERS
260HypoxiaFAERS: 13US FAERS
261IncontinenceFAERS: 13US FAERS
262Intentional product use issueFAERS: 13US FAERS
263NeutropeniaFAERS: 13US FAERS
264OpisthotonusFAERS: 13US FAERS
265PancreatitisFAERS: 13
Canada Vigilance: 3
Canada Vigilance
US FAERS
266Prescribed overdoseFAERS: 13US FAERS
267Reaction to drug excipientsFAERS: 13US FAERS
268Renal cystFAERS: 13US FAERS
269YawningFAERS: 13US FAERS
270Blood glucose abnormalFAERS: 12US FAERS
271Enamel anomalyFAERS: 12
Canada Vigilance: 1
Canada Vigilance
US FAERS
272GastritisFAERS: 12US FAERS
273Growth retardationFAERS: 12US FAERS
274Left atrial dilatationFAERS: 12US FAERS
275PresyncopeFAERS: 12US FAERS
276Right ventricle outflow tract obstructionFAERS: 12US FAERS
277AgoraphobiaFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
278Aortic Valve StenosisFAERS: 11US FAERS
279BlepharospasmFAERS: 11US FAERS
280Congenital heart valve disorderFAERS: 11US FAERS
281Congenital pulmonary hypertensionFAERS: 11US FAERS
282Drug effect delayedFAERS: 11US FAERS
283GastroschisisFAERS: 11US FAERS
284HungerFAERS: 11US FAERS
285Injury asphyxiationFAERS: 11US FAERS
286Left Ventricular HypertrophyFAERS: 11US FAERS
287Neuroleptic Malignant SyndromeFAERS: 11US FAERS
288PallorFAERS: 11US FAERS
289PlagiocephalyFAERS: 11US FAERS
290PneumothoraxFAERS: 11US FAERS
291Sinus bradycardiaFAERS: 11US FAERS
292Supraventricular tachycardiaFAERS: 11US FAERS
293ThrombosisFAERS: 11US FAERS
294Violence-related symptomFAERS: 11
Canada Vigilance: 3
Canada Vigilance
US FAERS
295Activation syndromeFAERS: 10US FAERS
296AnencephalyFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
297Angina PectorisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
298Blood triglycerides increasedFAERS: 10US FAERS
299ChokingFAERS: 10
Canada Vigilance: 3
Canada Vigilance
US FAERS
300ColitisFAERS: 10US FAERS
301Complications of maternal exposure to therapeutic drugsFAERS: 10US FAERS
302Conversion disorderFAERS: 10US FAERS
303Dacryostenosis congenitalFAERS: 10US FAERS
304DiplopiaFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
305Drug administration errorFAERS: 10US FAERS
306DysphemiaFAERS: 10US FAERS
307EnuresisFAERS: 10US FAERS
308Eosinophilic PneumoniaFAERS: 10US FAERS
309Gastric ulcerFAERS: 10US FAERS
310GastroenteritisFAERS: 10US FAERS
311HepatitisFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
312HyperparathyroidismFAERS: 10US FAERS
313HypokinesiaFAERS: 10US FAERS
314Loss of personal independence in daily activitiesFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
315Morbid thoughtsFAERS: 10US FAERS
316Psychomotor skills impairedFAERS: 10US FAERS
317Pulmonary EmbolismFAERS: 10US FAERS
318Pulmonary malformationFAERS: 10US FAERS
319Septic ShockFAERS: 10US FAERS
320SluggishnessFAERS: 10US FAERS
321ThirstFAERS: 10
Canada Vigilance: 1
Canada Vigilance
US FAERS
322Tooth LossFAERS: 10US FAERS
323ToothacheFAERS: 10US FAERS
324Vanishing bile duct syndromeFAERS: 10US FAERS
325Vitreous floatersFAERS: 10US FAERS
326Abnormal weight gainFAERS: 9US FAERS
327Back disorderFAERS: 9US FAERS
328Coronary Artery DiseaseFAERS: 9US FAERS
329Croup infectiousFAERS: 9US FAERS
330Disease ProgressionFAERS: 9US FAERS
331DysmorphismFAERS: 9US FAERS
332GlaucomaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
333Hallucinations, mixedFAERS: 9US FAERS
334HepatomegalyFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
335HyperacusisFAERS: 9US FAERS
336HyperventilationFAERS: 9US FAERS
337Inappropriate affectFAERS: 9US FAERS
338Inappropriate schedule of drug administrationFAERS: 9US FAERS
339Joint stiffnessFAERS: 9US FAERS
340Multiple SclerosisFAERS: 9US FAERS
341Neonatal aspirationFAERS: 9US FAERS
342Oromandibular dystoniaFAERS: 9US FAERS
343OsteoporosisFAERS: 9US FAERS
344Peripheral swellingFAERS: 9US FAERS
345PoisoningFAERS: 9US FAERS
346Pulmonary congestionFAERS: 9US FAERS
347SomnambulismFAERS: 9US FAERS
348Tardive DyskinesiaFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
349Atrioventricular Septal DefectFAERS: 8US FAERS
350Blood alkaline phosphatase increasedFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
351BradycardiaFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
352BronchiolitisFAERS: 8US FAERS
353BronchopneumoniaFAERS: 8US FAERS
354Cardiac FlutterFAERS: 8US FAERS
355Carpal Tunnel SyndromeFAERS: 8US FAERS
356Cerebral PalsyFAERS: 8US FAERS
357CystitisFAERS: 8US FAERS
358Drug ToleranceFAERS: 8US FAERS
359Drug exposure before pregnancyFAERS: 8US FAERS
360Drug level increasedFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
361Drug prescribing errorFAERS: 8US FAERS
362Educational problemFAERS: 8US FAERS
363Emotional povertyFAERS: 8US FAERS
364Gamma-Glutamyltransferase IncreasedFAERS: 8US FAERS
365Hypertensive crisisFAERS: 8US FAERS
366HyperthyroidismFAERS: 8US FAERS
367Intentional misuseFAERS: 8US FAERS
368Irritable Bowel SyndromeFAERS: 8US FAERS
369Low density lipoprotein increasedFAERS: 8US FAERS
370LymphomaFAERS: 8US FAERS
371MeningomyeloceleFAERS: 8US FAERS
372MenorrhagiaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
373Musculoskeletal PainFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
374Musculoskeletal chest painFAERS: 8US FAERS
375Nerve injuryFAERS: 8US FAERS
376Oral painFAERS: 8US FAERS
377Penile size reducedFAERS: 8US FAERS
378Rash erythematousFAERS: 8US FAERS
379RicketsFAERS: 8US FAERS
380SchizophreniaFAERS: 8US FAERS
381Self MutilationFAERS: 8US FAERS
382StomatitisFAERS: 8US FAERS
383Toxic Epidermal NecrolysisFAERS: 8US FAERS
384VasculitisFAERS: 8US FAERS
385AbasiaFAERS: 7US FAERS
386AngioedemaFAERS: 7US FAERS
387AnosmiaFAERS: 7US FAERS
388Apparent deathFAERS: 7US FAERS
389AstigmatismFAERS: 7US FAERS
390Bladder painFAERS: 7US FAERS
391BradyphreniaFAERS: 7US FAERS
392CellulitisFAERS: 7US FAERS
393CholelithiasisFAERS: 7US FAERS
394Congenital scoliosisFAERS: 7US FAERS
395Depression suicidalFAERS: 7US FAERS
396EcchymosisFAERS: 7US FAERS
397False positive investigation resultFAERS: 7US FAERS
398Gastric BypassFAERS: 7US FAERS
399Gastrointestinal PainFAERS: 7US FAERS
400HerniaFAERS: 7US FAERS
401HydronephrosisFAERS: 7US FAERS
402Intrusive thoughtsFAERS: 7US FAERS
403Macular degenerationFAERS: 7US FAERS
404NarcolepsyFAERS: 7US FAERS
405Oral candidiasisFAERS: 7US FAERS
406Poor quality drug administeredFAERS: 7US FAERS
407Pulmonary arterial hypertensionFAERS: 7US FAERS
408Renal tubular necrosisFAERS: 7US FAERS
409WheezingFAERS: 7US FAERS
410Antidepressant drug clearance decreasedFAERS: 6US FAERS
411AphoniaFAERS: 6US FAERS
412AsthenopiaFAERS: 6US FAERS
413Blood creatinine increasedFAERS: 6US FAERS
414Blood potassium decreasedFAERS: 6US FAERS
415Breech PresentationFAERS: 6US FAERS
416Bulimia NervosaFAERS: 6US FAERS
417Cerebral calcificationFAERS: 6US FAERS
418Circumstance or information capable of leading to medication errorFAERS: 6US FAERS
419ClinodactylyFAERS: 6US FAERS
420ConjunctivitisFAERS: 6US FAERS
421Cor TriatriatumFAERS: 6US FAERS
422Deep Vein ThrombosisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
423DextrocardiaFAERS: 6US FAERS
424Diaphragmatic HerniaFAERS: 6US FAERS
425Diffuse alveolar damageFAERS: 6US FAERS
426Disturbance in sexual arousalFAERS: 6US FAERS
427Ear congestionFAERS: 6US FAERS
428Electrolyte imbalanceFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
429Eye irritationFAERS: 6US FAERS
430Food AllergyFAERS: 6US FAERS
431HyperphagiaFAERS: 6US FAERS
432HypopituitarismFAERS: 6US FAERS
433Joint injuryFAERS: 6US FAERS
434LacerationFAERS: 6US FAERS
435Limb injuryFAERS: 6US FAERS
436Musculoskeletal discomfortFAERS: 6US FAERS
437NystagmusFAERS: 6US FAERS
438ObesityFAERS: 6US FAERS
439PetechiaeFAERS: 6US FAERS
440PharyngitisFAERS: 6US FAERS
441Pre-EclampsiaFAERS: 6US FAERS
442Product physical issueFAERS: 6US FAERS
443Pulmonary vascular disorderFAERS: 6US FAERS
444Renal painFAERS: 6US FAERS
445Rubinstein-Taybi SyndromeFAERS: 6US FAERS
446Sensory integrative dysfunctionFAERS: 6US FAERS
447ShockFAERS: 6US FAERS
448Ventricular hypoplasiaFAERS: 6US FAERS
449White blood cell count decreasedFAERS: 6US FAERS
450Wolf-Hirschhorn SyndromeFAERS: 6US FAERS
451Acute psychosisFAERS: 5US FAERS
452Alcohol interactionFAERS: 5US FAERS
453Antidepressant drug level increasedFAERS: 5US FAERS
454AphagiaFAERS: 5US FAERS
455Blood glucose decreasedFAERS: 5US FAERS
456Blood potassium increasedFAERS: 5US FAERS
457Bone painFAERS: 5US FAERS
458BronchomalaciaFAERS: 5US FAERS
459CatatoniaFAERS: 5US FAERS
460Chronic Fatigue SyndromeFAERS: 5US FAERS
461Congenital HydrocephalusFAERS: 5US FAERS
462Congenital choroid plexus cystFAERS: 5US FAERS
463Expired product administeredFAERS: 5US FAERS
464Facial PainFAERS: 5US FAERS
465Hepatitis CFAERS: 5US FAERS
466HepatotoxicityFAERS: 5US FAERS
467Hip DysplasiaFAERS: 5US FAERS
468HypophagiaFAERS: 5US FAERS
469HysterectomyFAERS: 5US FAERS
470IleusFAERS: 5US FAERS
471InfarctionFAERS: 5US FAERS
472InflammationFAERS: 5US FAERS
473Joint Range of Motion DecreasedFAERS: 5US FAERS
474LaryngomalaciaFAERS: 5US FAERS
475Limb asymmetryFAERS: 5US FAERS
476Lipase increasedFAERS: 5US FAERS
477LymphadenopathyFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
478MacrocephalyFAERS: 5US FAERS
479Male Orgasmic DisorderFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
480Male sexual dysfunctionFAERS: 5US FAERS
481Markedly reduced dietary intakeFAERS: 5US FAERS
482Metabolic acidosisFAERS: 5US FAERS
483Motion SicknessFAERS: 5US FAERS
484NephrolithiasisFAERS: 5US FAERS
485ParesisFAERS: 5US FAERS
486Premature EjaculationFAERS: 5US FAERS
487Reaction to excipientFAERS: 5US FAERS
488Retinal DetachmentFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
489Sinus ArrhythmiaFAERS: 5US FAERS
490Skin lacerationFAERS: 5US FAERS
491Skin reactionFAERS: 5US FAERS
492SneezingFAERS: 5US FAERS
493SnoringFAERS: 5US FAERS
494Stevens-Johnson SyndromeFAERS: 5US FAERS
495Suspected counterfeit productFAERS: 5US FAERS
496Unresponsive to stimuliFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
497Accidental deathFAERS: 4US FAERS
498Accidental drug intake by childFAERS: 4US FAERS
499Acute kidney injuryFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
500AppendicitisFAERS: 4US FAERS
501AtaxiaFAERS: 4US FAERS
502Atrial FibrillationFAERS: 4US FAERS
503Atrial tachycardiaFAERS: 4US FAERS
504Blood amylase increasedFAERS: 4US FAERS
505Blood cholesterol abnormalFAERS: 4US FAERS
506Blood pressure fluctuationFAERS: 4US FAERS
507BrachycephalyFAERS: 4US FAERS
508Bronchial HyperreactivityFAERS: 4US FAERS
509CHARGE SyndromeFAERS: 4US FAERS
510CardiotoxicityFAERS: 4US FAERS
511Cerebral InfarctionFAERS: 4US FAERS
512Childhood disintegrative disorderFAERS: 4US FAERS
513CholesteatomaFAERS: 4US FAERS
514ChoreoathetosisFAERS: 4US FAERS
515Chronic sinusitisFAERS: 4US FAERS
516Congenital nystagmusFAERS: 4US FAERS
517Coronary artery insufficiencyFAERS: 4US FAERS
518Delusional perceptionFAERS: 4US FAERS
519Diastolic dysfunctionFAERS: 4US FAERS
520Drug abuserFAERS: 4US FAERS
521Drug administered to patient of inappropriate ageFAERS: 4US FAERS
522Drug effective for unapproved indicationFAERS: 4US FAERS
523Drug resistanceFAERS: 4US FAERS
524Ear discomfortFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
525Ectopia CordisFAERS: 4US FAERS
526Electroencephalogram abnormalFAERS: 4US FAERS
527Erythema MultiformeFAERS: 4US FAERS
528Essential TremorFAERS: 4US FAERS
529Exfoliative rashFAERS: 4US FAERS
530Febrile infectionFAERS: 4US FAERS
531Feeding disorder of infancy OR early childhoodFAERS: 4US FAERS
532Food cravingFAERS: 4US FAERS
533Gait inabilityFAERS: 4US FAERS
534Gastrointestinal hypomotilityFAERS: 4US FAERS
535HemiparesisFAERS: 4US FAERS
536HypoventilationFAERS: 4US FAERS
537ImpatienceFAERS: 4US FAERS
538IncoherentFAERS: 4US FAERS
539Increased tendency to bruiseFAERS: 4US FAERS
540Initial insomniaFAERS: 4US FAERS
541Intestinal ObstructionFAERS: 4US FAERS
542Lactose IntoleranceFAERS: 4US FAERS
543LeukopeniaFAERS: 4US FAERS
544Libido disorderFAERS: 4US FAERS
545Long QT SyndromeFAERS: 4US FAERS
546MalabsorptionFAERS: 4US FAERS
547MalnutritionFAERS: 4US FAERS
548MetrorrhagiaFAERS: 4US FAERS
549MicrocephalyFAERS: 4US FAERS
550MonoplegiaFAERS: 4US FAERS
551Multiple drug overdoseFAERS: 4US FAERS
552MyositisFAERS: 4US FAERS
553Neutrophil count decreasedFAERS: 4US FAERS
554NocturiaFAERS: 4US FAERS
555Optic NeuritisFAERS: 4US FAERS
556Optic nerve cup/disc ratio increasedFAERS: 4US FAERS
557Pericardial effusionFAERS: 4US FAERS
558PharyngotonsillitisFAERS: 4US FAERS
559PriapismFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
560Procedural complicationFAERS: 4US FAERS
561Product coating issueFAERS: 4US FAERS
562Product dose omissionFAERS: 4US FAERS
563Psychiatric decompensationFAERS: 4US FAERS
564Pulmonary artery stenosisFAERS: 4US FAERS
565Rectal ProlapseFAERS: 4US FAERS
566Retinopathy of PrematurityFAERS: 4US FAERS
567Schizoaffective DisorderFAERS: 4US FAERS
568Secretion dischargeFAERS: 4US FAERS
569Sjogren's SyndromeFAERS: 4US FAERS
570Somatoform DisorderFAERS: 4US FAERS
571SoporFAERS: 4US FAERS
572Sperm count decreasedFAERS: 4US FAERS
573Sudden deathFAERS: 4US FAERS
574TheftFAERS: 4US FAERS
575Therapeutic response changedFAERS: 4US FAERS
576TracheomalaciaFAERS: 4US FAERS
577VIIth nerve paralysisFAERS: 4US FAERS
578Vaginal DischargeFAERS: 4US FAERS
579Vascular anomalyFAERS: 4US FAERS
580Abnormal sleep-related eventFAERS: 3US FAERS
581Accidental exposureFAERS: 3US FAERS
582Acute sinusitisFAERS: 3US FAERS
583AgeusiaFAERS: 3US FAERS
584AkinesiaFAERS: 3US FAERS
585Alcohol abuseFAERS: 3US FAERS
586AneurysmFAERS: 3US FAERS
587Benign Prostatic HyperplasiaFAERS: 3US FAERS
588Benign neoplasm of spinal cordFAERS: 3US FAERS
589Blood alcohol increasedFAERS: 3US FAERS
590Blood homocysteine increasedFAERS: 3US FAERS
591Blood lactate dehydrogenase increasedFAERS: 3US FAERS
592Blood urea increasedFAERS: 3US FAERS
593Blood urine presentFAERS: 3US FAERS
594Blunted affectFAERS: 3US FAERS
595Bone density decreasedFAERS: 3US FAERS
596Bowel movement irregularityFAERS: 3US FAERS
597Breast tendernessFAERS: 3US FAERS
598CandidiasisFAERS: 3US FAERS
599CataractFAERS: 3US FAERS
600Cerebral vasoconstrictionFAERS: 3US FAERS
601CholecystitisFAERS: 3US FAERS
602ChoreaFAERS: 3US FAERS
603Cleft uvulaFAERS: 3US FAERS
604ClonusFAERS: 3US FAERS
605Congenital renal disorderFAERS: 3US FAERS
606DermatitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
607Dermoid CystFAERS: 3US FAERS
608DiverticulitisFAERS: 3US FAERS
609DrowningFAERS: 3US FAERS
610Drug withdrawal headacheFAERS: 3US FAERS
611DyspareuniaFAERS: 3US FAERS
612Dysthymic DisorderFAERS: 3US FAERS
613EructationFAERS: 3US FAERS
614Essential HypertensionFAERS: 3US FAERS
615Excessive eye blinkingFAERS: 3US FAERS
616Expired drug administeredFAERS: 3US FAERS
617Exposure via breast milkFAERS: 3US FAERS
618Extra dose administeredFAERS: 3US FAERS
619Fanconi SyndromeFAERS: 3US FAERS
620FumblingFAERS: 3US FAERS
621Gastric infectionFAERS: 3US FAERS
622Gestational DiabetesFAERS: 3US FAERS
623Glucocorticoid deficiencyFAERS: 3US FAERS
624Gluten sensitivityFAERS: 3US FAERS
625Head circumference abnormalFAERS: 3US FAERS
626Heat StrokeFAERS: 3US FAERS
627HeterophoriaFAERS: 3US FAERS
628HoloprosencephalyFAERS: 3US FAERS
629Hormone level abnormalFAERS: 3US FAERS
630Hypothalamo-pituitary disorderFAERS: 3US FAERS
631ImmobileFAERS: 3US FAERS
632Infantile apnoeic attackFAERS: 3US FAERS
633InfertilityFAERS: 3US FAERS
634Intestinal FistulaFAERS: 3US FAERS
635Lacrimation decreasedFAERS: 3US FAERS
636LaryngitisFAERS: 3US FAERS
637Lichen PlanusFAERS: 3US FAERS
638Lipids abnormalFAERS: 3US FAERS
639Low birth weight babyFAERS: 3US FAERS
640Lower respiratory tract infectionFAERS: 3US FAERS
641LymphadenitisFAERS: 3US FAERS
642MeningiomaFAERS: 3US FAERS
643MeningitisFAERS: 3US FAERS
644MenopauseFAERS: 3US FAERS
645Mental RetardationFAERS: 3US FAERS
646Migraine with AuraFAERS: 3US FAERS
647Mitral Valve StenosisFAERS: 3US FAERS
648Multiple sclerosis relapseFAERS: 3US FAERS
649Muscle CrampFAERS: 3US FAERS
650MyocarditisFAERS: 3US FAERS
651Myoclonic EpilepsyFAERS: 3US FAERS
652MyopathyFAERS: 3US FAERS
653NeuralgiaFAERS: 3US FAERS
654Ocular discomfortFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
655Oculomucocutaneous syndromeFAERS: 3US FAERS
656Oppositional Defiant DisorderFAERS: 3US FAERS
657Optic AtrophyFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
658Oropharyngeal swellingFAERS: 3US FAERS
659OsteopeniaFAERS: 3US FAERS
660OverweightFAERS: 3US FAERS
661Pain of skinFAERS: 3US FAERS
662Partner stressFAERS: 3US FAERS
663Patient IsolationFAERS: 3US FAERS
664PericarditisFAERS: 3US FAERS
665Platelet aggregationFAERS: 3US FAERS
666PleurothotonusFAERS: 3US FAERS
667PolydactylyFAERS: 3US FAERS
668Premenstrual syndromeFAERS: 3US FAERS
669Prescribed underdoseFAERS: 3US FAERS
670Pressure of speechFAERS: 3US FAERS
671Product counterfeitFAERS: 3US FAERS
672Product solubility abnormalFAERS: 3US FAERS
673ProlactinomaFAERS: 3US FAERS
674Pulmonary FibrosisFAERS: 3US FAERS
675Pyloric StenosisFAERS: 3US FAERS
676Sensation of blood flowFAERS: 3US FAERS
677Serum serotonin decreasedFAERS: 3US FAERS
678Sexual abuseFAERS: 3US FAERS
679Shone complexFAERS: 3US FAERS
680Single functional kidneyFAERS: 3US FAERS
681Skin PapillomaFAERS: 3US FAERS
682SoliloquyFAERS: 3US FAERS
683Spermatozoa abnormalFAERS: 3US FAERS
684Spontaneous penile erectionFAERS: 3US FAERS
685Subacute hepatic failureFAERS: 3US FAERS
686Supravalvular aortic stenosisFAERS: 3US FAERS
687SyndactylyFAERS: 3US FAERS
688Tension HeadacheFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
689Therapeutic product effect incompleteFAERS: 3
Canada Vigilance: 6
Canada Vigilance
US FAERS
690Thermal burnFAERS: 3US FAERS
691Tongue blisteringFAERS: 3US FAERS
692Tricuspid Valve StenosisFAERS: 3US FAERS
693UlcerFAERS: 3US FAERS
694UnderweightFAERS: 3US FAERS
695Ventricular hypertrophyFAERS: 3US FAERS
696Vocal Cord ParalysisFAERS: 3US FAERS
697Vulvovaginal discomfortFAERS: 3US FAERS
698Vulvovaginal pruritusFAERS: 3US FAERS
699Wound infection staphylococcalFAERS: 3US FAERS
700treatment failureFAERS: 3US FAERS
701AbscessFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
702Accidental exposure to productFAERS: 2US FAERS
703Accidental exposure to product by childFAERS: 2US FAERS
704Acute myocardial infarctionFAERS: 2US FAERS
705Acute prerenal failureFAERS: 2US FAERS
706Acute respiratory failureFAERS: 2US FAERS
707Alanine aminotransferase abnormalFAERS: 2US FAERS
708Alcohol poisoningFAERS: 2US FAERS
709Allergic colitisFAERS: 2US FAERS
710Allergy to chemicalsFAERS: 2US FAERS
711Ammonia increasedFAERS: 2US FAERS
712Ankle FractureFAERS: 2US FAERS
713Aphthous StomatitisFAERS: 2US FAERS
714Apparent life threatening eventFAERS: 2US FAERS
715AscitesFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
716Aspartate aminotransferase abnormalFAERS: 2US FAERS
717Atrioventricular BlockFAERS: 2US FAERS
718Auricular swellingFAERS: 2US FAERS
719Autoimmune thyroiditisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
720Autonomic nervous system imbalanceFAERS: 2US FAERS
721AutophonyFAERS: 2US FAERS
722AutoscopyFAERS: 2US FAERS
723Bacterial tracheitisFAERS: 2US FAERS
724BelligerenceFAERS: 2US FAERS
725Bladder discomfortFAERS: 2US FAERS
726Bladder spasmFAERS: 2US FAERS
727Blood blisterFAERS: 2US FAERS
728Blood creatine increasedFAERS: 2US FAERS
729Blood creatinine decreasedFAERS: 2US FAERS
730Blood glucose fluctuationFAERS: 2US FAERS
731Blood iron decreasedFAERS: 2US FAERS
732Blood magnesium decreasedFAERS: 2US FAERS
733Blood pH decreasedFAERS: 2US FAERS
734Blood prolactin increasedFAERS: 2US FAERS
735Blood thyroid stimulating hormone abnormalFAERS: 2US FAERS
736Blood thyroid stimulating hormone decreasedFAERS: 2US FAERS
737Body height below normalFAERS: 2US FAERS
738Borderline Personality DisorderFAERS: 2US FAERS
739Brain HypoxiaFAERS: 2US FAERS
740Breast cancer recurrentFAERS: 2US FAERS
741Caput succedaneumFAERS: 2US FAERS
742Caudal Regression SyndromeFAERS: 2US FAERS
743Central nervous system lesionFAERS: 2US FAERS
744Cerebral atrophyFAERS: 2US FAERS
745Cerebral cystFAERS: 2US FAERS
746ChromatopsiaFAERS: 2US FAERS
747ClumsinessFAERS: 2US FAERS
748Compulsive sexual behaviourFAERS: 2US FAERS
749Congenital absence of cranial vaultFAERS: 2US FAERS
750Congenital hydronephrosisFAERS: 2US FAERS
751Congenital torticollisFAERS: 2US FAERS
752Congenital tracheomalaciaFAERS: 2US FAERS
753Deafness NeurosensoryFAERS: 2US FAERS
754DeformityFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
755Deja VuFAERS: 2US FAERS
756Delayed deliveryFAERS: 2US FAERS
757Delusion of referenceFAERS: 2US FAERS
758DemyelinationFAERS: 2US FAERS
759DiplegiaFAERS: 2US FAERS
760Dissociative disorderFAERS: 2US FAERS
761Dreamy stateFAERS: 2US FAERS
762DroolingFAERS: 2US FAERS
763Drug addictFAERS: 2US FAERS
764Drug label confusionFAERS: 2US FAERS
765Drug level decreasedFAERS: 2US FAERS
766Dumping SyndromeFAERS: 2US FAERS
767Duodenal atresiaFAERS: 2US FAERS
768Electrocardiogram ST segment abnormalFAERS: 2US FAERS
769EndometriosisFAERS: 2US FAERS
770Enterococcal infectionFAERS: 2US FAERS
771EosinophiliaFAERS: 2US FAERS
772Epigastric discomfortFAERS: 2US FAERS
773Erection increasedFAERS: 2US FAERS
774ExcoriationFAERS: 2US FAERS
775ExophthalmosFAERS: 2US FAERS
776Exposure to toxic agentFAERS: 2US FAERS
777Exposure via fatherFAERS: 2US FAERS
778Facial ParesisFAERS: 2US FAERS
779Fear of fallingFAERS: 2US FAERS
780Feeling of body temperature changeFAERS: 2US FAERS
781Female Orgasmic DisorderFAERS: 2US FAERS
782Female sexual arousal disorderFAERS: 2US FAERS
783Flight of ideasFAERS: 2US FAERS
784Gastric DilatationFAERS: 2US FAERS
785Gastrointestinal motility disorderFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
786Gastrointestinal sounds abnormalFAERS: 2US FAERS
787General physical condition abnormalFAERS: 2US FAERS
788GlomerulonephritisFAERS: 2US FAERS
789GlossitisFAERS: 2US FAERS
790Granuloma AnnulareFAERS: 2US FAERS
791Guillain-Barre SyndromeFAERS: 2US FAERS
792HELLP SyndromeFAERS: 2US FAERS
793Head BangingFAERS: 2US FAERS
794HemiplegiaFAERS: 2US FAERS
795Hepatic EncephalopathyFAERS: 2US FAERS
796Hyperdynamic left ventricleFAERS: 2US FAERS
797Hypermobility syndromeFAERS: 2US FAERS
798Hypertrophic CardiomyopathyFAERS: 2US FAERS
799HypervigilanceFAERS: 2US FAERS
800Hypoaesthesia facialFAERS: 2US FAERS
801Inappropriate PrescribingFAERS: 2US FAERS
802Incorrect route of drug administrationFAERS: 2US FAERS
803Increased upper airway secretionFAERS: 2US FAERS
804IniencephalyFAERS: 2US FAERS
805Intelligence test abnormalFAERS: 2US FAERS
806Intestinal resectionFAERS: 2US FAERS
807Intracranial injuryFAERS: 2US FAERS
808Iron deficiencyFAERS: 2US FAERS
809Joint sprainFAERS: 2US FAERS
810Limb discomfortFAERS: 2US FAERS
811Lung hyperinflationFAERS: 2US FAERS
812Lupus-like syndromeFAERS: 2US FAERS
813Lymphatic system neoplasmFAERS: 2US FAERS
814Lymphocyte percentage decreasedFAERS: 2US FAERS
815Magnesium DeficiencyFAERS: 2US FAERS
816MarasmusFAERS: 2US FAERS
817Mastication disorderFAERS: 2US FAERS
818MastitisFAERS: 2US FAERS
819Medication residue presentFAERS: 2US FAERS
820Mineral deficiencyFAERS: 2US FAERS
821MoroseFAERS: 2US FAERS
822Multi-organ disorderFAERS: 2US FAERS
823Multiple Chemical SensitivityFAERS: 2US FAERS
824Muscle FatigueFAERS: 2US FAERS
825Muscle SpasticityFAERS: 2US FAERS
826MutismFAERS: 2US FAERS
827Myocardial calcificationFAERS: 2US FAERS
828Myoglobin blood increasedFAERS: 2US FAERS
829Nasal discomfortFAERS: 2US FAERS
830Neonatal respiratory failureFAERS: 2US FAERS
831Neutrophil percentage increasedFAERS: 2US FAERS
832Noonan SyndromeFAERS: 2US FAERS
833Obesity surgeryFAERS: 2US FAERS
834Open woundFAERS: 2US FAERS
835Oropharyngeal blisteringFAERS: 2US FAERS
836Oropharyngeal discomfortFAERS: 2US FAERS
837Oropharyngeal plaqueFAERS: 2US FAERS
838OsteomyelitisFAERS: 2US FAERS
839Pancreatic carcinomaFAERS: 2US FAERS
840Paradoxical drug reactionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
841Pectus carinatumFAERS: 2US FAERS
842Pectus excavatumFAERS: 2US FAERS
843Pelvic PainFAERS: 2US FAERS
844Performance status decreasedFAERS: 2US FAERS
845Pharyngeal swellingFAERS: 2US FAERS
846Physical abuseFAERS: 2US FAERS
847Physical disabilityFAERS: 2US FAERS
848Platelet aggregation decreasedFAERS: 2US FAERS
849Platelet function test abnormalFAERS: 2US FAERS
850PolydipsiaFAERS: 2US FAERS
851PolyuriaFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
852Poor quality product administeredFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
853PoriomaniaFAERS: 2US FAERS
854Prescription drug used without a prescriptionFAERS: 2US FAERS
855Product dispensing errorFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
856Product dropper issueFAERS: 2US FAERS
857Product formulation issueFAERS: 2US FAERS
858Product measured potency issueFAERS: 2US FAERS
859Product storage errorFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
860Progesterone decreasedFAERS: 2US FAERS
861Pustular psoriasisFAERS: 2US FAERS
862Rash neonatalFAERS: 2US FAERS
863Rectal dischargeFAERS: 2US FAERS
864Reflux laryngitisFAERS: 2US FAERS
865RegurgitationFAERS: 2US FAERS
866Respiratory muscle weaknessFAERS: 2US FAERS
867SciaticaFAERS: 2US FAERS
868ScotomaFAERS: 2US FAERS
869Senile dementiaFAERS: 2US FAERS
870Sicca SyndromeFAERS: 2US FAERS
871Sinus headacheFAERS: 2US FAERS
872Skin lesionFAERS: 2US FAERS
873Sleep TalkingFAERS: 2US FAERS
874Spinal Muscular AtrophyFAERS: 2US FAERS
875StuporFAERS: 2US FAERS
876Subgaleal haematomaFAERS: 2US FAERS
877Sudden Cardiac DeathFAERS: 2US FAERS
878Suppressed lactationFAERS: 2US FAERS
879Temperature intoleranceFAERS: 2US FAERS
880TenosynovitisFAERS: 2US FAERS
881Tethered Cord SyndromeFAERS: 2US FAERS
882Therapy non-responderFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
883Thrombocytopenic purpuraFAERS: 2US FAERS
884ThrombocytosisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
885ThyroiditisFAERS: 2US FAERS
886Tobacco userFAERS: 2US FAERS
887Tongue bitingFAERS: 2US FAERS
888Tongue exfoliationFAERS: 2US FAERS
889Transaminases increasedFAERS: 2US FAERS
890Transfusion ReactionFAERS: 2US FAERS
891Troponin increasedFAERS: 2US FAERS
892Tympanic Membrane PerforationFAERS: 2US FAERS
893Typhoid FeverFAERS: 2US FAERS
894UnemploymentFAERS: 2US FAERS
895Urinary hesitationFAERS: 2US FAERS
896Uterine CancerFAERS: 2US FAERS
897Uterine ProlapseFAERS: 2US FAERS
898Uterine RuptureFAERS: 2US FAERS
899Victim of sexual abuseFAERS: 2US FAERS
900Vitamin D DeficiencyFAERS: 2US FAERS
901effusionFAERS: 2US FAERS
902furuncleFAERS: 2US FAERS
903muscle injuryFAERS: 2US FAERS
904ovarian neoplasmFAERS: 2US FAERS
905prostatitisFAERS: 2US FAERS
906Abdominal tendernessFAERS: 1US FAERS
907Abnormal palmar/plantar creasesFAERS: 1US FAERS
908AbuliaFAERS: 1US FAERS
909Acute Coronary SyndromeFAERS: 1US FAERS
910Acute fatty liver of pregnancyFAERS: 1US FAERS
911AgnosiaFAERS: 1US FAERS
912AgraphiaFAERS: 1US FAERS
913Alcohol problemFAERS: 1US FAERS
914Allergic reaction to excipientFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
915AllodyniaFAERS: 1US FAERS
916Alopecia AreataFAERS: 1US FAERS
917Altered visual depth perceptionFAERS: 1US FAERS
918AlveolitisFAERS: 1US FAERS
919Amino acid level decreasedFAERS: 1US FAERS
920Amniotic fluid volume decreasedFAERS: 1US FAERS
921Amniotic fluid volume increasedFAERS: 1US FAERS
922Anaphylactic shockFAERS: 1US FAERS
923AngioplastyFAERS: 1US FAERS
924Angle Closure GlaucomaFAERS: 1US FAERS
925AnisocytosisFAERS: 1US FAERS
926AnisometropiaFAERS: 1US FAERS
927Anticholinergic SyndromeFAERS: 1US FAERS
928Anticoagulation drug level above therapeuticFAERS: 1US FAERS
929Antinuclear antibody increasedFAERS: 1US FAERS
930Antipsychotic drug level increasedFAERS: 1US FAERS
931Antisocial Personality DisorderFAERS: 1US FAERS
932AnuriaFAERS: 1US FAERS
933Aortic AneurysmFAERS: 1US FAERS
934Aortic elongationFAERS: 1US FAERS
935Aortic valve sclerosisFAERS: 1US FAERS
936Apallic syndromeFAERS: 1US FAERS
937Aqueductal StenosisFAERS: 1US FAERS
938Arterial insufficiencyFAERS: 1US FAERS
939ArteriosclerosisFAERS: 1US FAERS
940ArthroscopyFAERS: 1US FAERS
941AstrocytomaFAERS: 1US FAERS
942Atrial bigeminyFAERS: 1US FAERS
943Atrial pressure increasedFAERS: 1US FAERS
944Bacterial disease carrierFAERS: 1US FAERS
945BankruptcyFAERS: 1US FAERS
946Barbiturates positiveFAERS: 1US FAERS
947Bed restFAERS: 1US FAERS
948Bladder papillomaFAERS: 1US FAERS
949Bladder prolapseFAERS: 1US FAERS
950Blood albumin increasedFAERS: 1US FAERS
951Blood alcohol abnormalFAERS: 1US FAERS
952Blood aldosterone increasedFAERS: 1US FAERS
953Blood chloride decreasedFAERS: 1US FAERS
954Blood copper increasedFAERS: 1US FAERS
955Blood immunoglobulin E increasedFAERS: 1US FAERS
956Blood magnesium increasedFAERS: 1US FAERS
957Blood pH increasedFAERS: 1US FAERS
958Blood phosphorus decreasedFAERS: 1US FAERS
959Blood potassium abnormalFAERS: 1US FAERS
960Blood pressure immeasurableFAERS: 1US FAERS
961Blood testosterone decreasedFAERS: 1US FAERS
962Blood thyroid stimulating hormone increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
963Bone fissureFAERS: 1US FAERS
964Bone formation decreasedFAERS: 1US FAERS
965Bone lesionFAERS: 1US FAERS
966Bone marrow depressionFAERS: 1US FAERS
967BradykinesiaFAERS: 1US FAERS
968Breast FeedingFAERS: 1US FAERS
969Breast engorgementFAERS: 1US FAERS
970Breath alcohol test positiveFAERS: 1US FAERS
971Bronchial irritationFAERS: 1US FAERS
972BronchiectasisFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
973BronchospasmFAERS: 1US FAERS
974BursitisFAERS: 1US FAERS
975Butterfly rashFAERS: 1US FAERS
976Capsular contracture associated with breast implantFAERS: 1US FAERS
977Carbon Monoxide PoisoningFAERS: 1US FAERS
978Carbon dioxide increasedFAERS: 1US FAERS
979Carcinoembryonic antigen increasedFAERS: 1US FAERS
980CarcinomaFAERS: 1US FAERS
981Cardiac discomfortFAERS: 1US FAERS
982Cardiac perforationFAERS: 1US FAERS
983Cardiac procedure complicationFAERS: 1US FAERS
984Cartilage injuryFAERS: 1US FAERS
985Cerebral ArteriosclerosisFAERS: 1US FAERS
986Cerebral ventricle dilatationFAERS: 1US FAERS
987Cervicobrachial syndromeFAERS: 1US FAERS
988Cervix carcinomaFAERS: 1US FAERS
989Charles Bonnet SyndromeFAERS: 1US FAERS
990ChemotherapyFAERS: 1US FAERS
991Choking sensationFAERS: 1US FAERS
992CholangiolitisFAERS: 1US FAERS
993CholangitisFAERS: 1US FAERS
994ChorioamnionitisFAERS: 1US FAERS
995Chronic gastritisFAERS: 1US FAERS
996ChylothoraxFAERS: 1US FAERS
997ClaustrophobiaFAERS: 1US FAERS
998ClutteringFAERS: 1US FAERS
999Cogwheel RigidityFAERS: 1US FAERS
1000Coma scale abnormalFAERS: 1US FAERS
1001Complex partial seizuresFAERS: 1US FAERS
1002Compression fractureFAERS: 1US FAERS
1003Congenital HypothyroidismFAERS: 1US FAERS
1004Congenital Nephrogenic Diabetes InsipidusFAERS: 1US FAERS
1005Congenital cystic kidney diseaseFAERS: 1US FAERS
1006Congenital diaphragmatic herniaFAERS: 1US FAERS
1007Congenital hearing disorderFAERS: 1US FAERS
1008Congenital hepatobiliary anomalyFAERS: 1US FAERS
1009Congenital hepatomegalyFAERS: 1US FAERS
1010Congenital inguinal herniaFAERS: 1US FAERS
1011Congenital intestinal malformationFAERS: 1US FAERS
1012Congenital skin dimplesFAERS: 1US FAERS
1013Contraindicated drug administeredFAERS: 1US FAERS
1014Contraindicated product administeredFAERS: 1US FAERS
1015Coombs test positiveFAERS: 1US FAERS
1016Counterfeit drug administeredFAERS: 1US FAERS
1017Cystic FibrosisFAERS: 1US FAERS
1018CystopexyFAERS: 1US FAERS
1019CystFAERS: 1US FAERS
1020Cytolytic hepatitisFAERS: 1US FAERS
1021Dacryostenosis acquiredFAERS: 1US FAERS
1022Dandy-Walker SyndromeFAERS: 1US FAERS
1023Death of childFAERS: 1US FAERS
1024Decorticate postureFAERS: 1US FAERS
1025Dehydroepiandrosterone increasedFAERS: 1US FAERS
1026Dengue FeverFAERS: 1US FAERS
1027Dependent Personality DisorderFAERS: 1US FAERS
1028Developmental Coordination DisorderFAERS: 1US FAERS
1029Device FailureFAERS: 1US FAERS
1030Device dislocationFAERS: 1US FAERS
1031Device ineffectiveFAERS: 1US FAERS
1032Diabetes InsipidusFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1033Diabetes mellitus inadequate controlFAERS: 1US FAERS
1034Dissociative AmnesiaFAERS: 1US FAERS
1035DiverticulumFAERS: 1US FAERS
1036Dopamine dysregulation syndromeFAERS: 1US FAERS
1037Drug clearance decreasedFAERS: 1US FAERS
1038Drug cross-reactivityFAERS: 1US FAERS
1039Drug dispensed to wrong patientFAERS: 1US FAERS
1040Drug effect variableFAERS: 1US FAERS
1041Drug level below therapeuticFAERS: 1US FAERS
1042Drug withdrawal convulsionsFAERS: 1US FAERS
1043DuodenitisFAERS: 1US FAERS
1044DysenteryFAERS: 1US FAERS
1045DyslexiaFAERS: 1US FAERS
1046EclampsiaFAERS: 1US FAERS
1047Electrocardiogram QT interval abnormalFAERS: 1US FAERS
1048Electrocardiogram repolarisation abnormalityFAERS: 1US FAERS
1049Elevated moodFAERS: 1US FAERS
1050EmbolismFAERS: 1US FAERS
1051EncephaloceleFAERS: 1US FAERS
1052EncephalomalaciaFAERS: 1US FAERS
1053Environmental ExposureFAERS: 1US FAERS
1054Enzyme abnormalityFAERS: 1US FAERS
1055EpicondylitisFAERS: 1US FAERS
1056Erosive DuodenitisFAERS: 1US FAERS
1057ErysipelasFAERS: 1US FAERS
1058Erythema NodosumFAERS: 1US FAERS
1059ExcitabilityFAERS: 1US FAERS
1060Executive dysfunctionFAERS: 1US FAERS
1061Exposure via partnerFAERS: 1US FAERS
1062ExtravasationFAERS: 1US FAERS
1063Extremity necrosisFAERS: 1US FAERS
1064Eye BurnsFAERS: 1US FAERS
1065Eye ulcerFAERS: 1US FAERS
1066Facial NeuralgiaFAERS: 1US FAERS
1067Facial paralysisFAERS: 1US FAERS
1068Female sexual dysfunctionFAERS: 1US FAERS
1069Flank PainFAERS: 1US FAERS
1070Foaming at mouthFAERS: 1US FAERS
1071FolliculitisFAERS: 1US FAERS
1072Food aversionFAERS: 1US FAERS
1073Food hoardingFAERS: 1US FAERS
1074Foreign body aspirationFAERS: 1US FAERS
1075Foreign body in respiratory tractFAERS: 1US FAERS
1076Foreign body sensation in eyesFAERS: 1US FAERS
1077Foreign body traumaFAERS: 1US FAERS
1078Frontotemporal dementiaFAERS: 1US FAERS
1079FrostbiteFAERS: 1US FAERS
1080Frustration tolerance decreasedFAERS: 1US FAERS
1081Full blood count abnormalFAERS: 1US FAERS
1082Gamma-glutamyltransferase decreasedFAERS: 1US FAERS
1083GangreneFAERS: 1US FAERS
1084GastrectomyFAERS: 1US FAERS
1085Gastrointestinal inflammationFAERS: 1US FAERS
1086Gastrointestinal viral infectionFAERS: 1US FAERS
1087General symptomFAERS: 1US FAERS
1088Genital burning sensationFAERS: 1US FAERS
1089Genital tract inflammationFAERS: 1US FAERS
1090Gingival erythemaFAERS: 1US FAERS
1091GingivitisFAERS: 1US FAERS
1092GoutFAERS: 1US FAERS
1093Hand-eye coordination impairedFAERS: 1US FAERS
1094Head titubationFAERS: 1US FAERS
1095Hearing disabilityFAERS: 1US FAERS
1096Heart sounds abnormalFAERS: 1US FAERS
1097Heart valve stenosisFAERS: 1US FAERS
1098Hereditary spherocytosisFAERS: 1US FAERS
1099HeteroplasiaFAERS: 1US FAERS
1100Histamine intoleranceFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1101Histone antibody positiveFAERS: 1US FAERS
1102Histrionic Personality DisorderFAERS: 1US FAERS
1103Holt-Oram syndromeFAERS: 1US FAERS
1104House dust allergyFAERS: 1US FAERS
1105Human EhrlichiosisFAERS: 1US FAERS
1106HyperchlorhydriaFAERS: 1US FAERS
1107HypergeusiaFAERS: 1US FAERS
1108HyperkinesiaFAERS: 1US FAERS
1109HyperpyrexiaFAERS: 1US FAERS
1110HypertrophyFAERS: 1US FAERS
1111HypervitaminosisFAERS: 1US FAERS
1112HypogeusiaFAERS: 1US FAERS
1113HypometabolismFAERS: 1US FAERS
1114Hypothermia neonatalFAERS: 1US FAERS
1115Iatrogenic injuryFAERS: 1US FAERS
1116Idiosyncratic drug reactionFAERS: 1US FAERS
1117IlliteracyFAERS: 1US FAERS
1118Impaired gastric emptyingFAERS: 1US FAERS
1119Impaired self-careFAERS: 1US FAERS
1120Inability to afford medicationFAERS: 1US FAERS
1121Incision site abscessFAERS: 1US FAERS
1122Incision site complicationFAERS: 1US FAERS
1123Incorrect product storageFAERS: 1US FAERS
1124Infantile asthmaFAERS: 1US FAERS
1125Infectious MononucleosisFAERS: 1US FAERS
1126Inferior vena cava dilatationFAERS: 1US FAERS
1127Insulin ResistanceFAERS: 1US FAERS
1128Intelligence increasedFAERS: 1US FAERS
1129Intervertebral Disc DegenerationFAERS: 1US FAERS
1130Intervertebral disc annular tearFAERS: 1US FAERS
1131Intervertebral disc disorderFAERS: 1US FAERS
1132Intracranial AneurysmFAERS: 1US FAERS
1133Intracranial HypotensionFAERS: 1US FAERS
1134Intraocular pressure test abnormalFAERS: 1US FAERS
1135IritisFAERS: 1US FAERS
1136KeratitisFAERS: 1US FAERS
1137Labile blood pressureFAERS: 1US FAERS
1138Lack of spontaneous speechFAERS: 1US FAERS
1139Lactation DisorderFAERS: 1US FAERS
1140Large intestine perforationFAERS: 1US FAERS
1141LaryngospasmFAERS: 1US FAERS
1142LazinessFAERS: 1US FAERS
1143Lennox-Gastaut syndromeFAERS: 1US FAERS
1144LeukocytosisFAERS: 1US FAERS
1145LeukoplakiaFAERS: 1US FAERS
1146Ligament ruptureFAERS: 1US FAERS
1147Limited symptom panic attackFAERS: 1US FAERS
1148Lip exfoliationFAERS: 1US FAERS
1149Lip pruritusFAERS: 1US FAERS
1150LipomaFAERS: 1US FAERS
1151Loose toothFAERS: 1US FAERS
1152Loss of dreamingFAERS: 1US FAERS
1153Low set earsFAERS: 1US FAERS
1154Lung InjuryFAERS: 1US FAERS
1155Lymphoid tissue hyperplasiaFAERS: 1US FAERS
1156Lymphomatoid PapulosisFAERS: 1US FAERS
1157MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
1158Malignant neoplasm progressionFAERS: 1US FAERS
1159MalocclusionFAERS: 1US FAERS
1160Maternal exposure before pregnancyFAERS: 1US FAERS
1161Meconium Aspiration SyndromeFAERS: 1US FAERS
1162Meconium ileusFAERS: 1US FAERS
1163Medication residueFAERS: 1US FAERS
1164MegacolonFAERS: 1US FAERS
1165Mental retardation severity unspecifiedFAERS: 1US FAERS
1166Mentally late developerFAERS: 1US FAERS
1167MetastasisFAERS: 1US FAERS
1168MicrocytosisFAERS: 1US FAERS
1169Milk AllergyFAERS: 1US FAERS
1170Monoclonal immunoglobulin presentFAERS: 1US FAERS
1171Monocyte percentage decreasedFAERS: 1US FAERS
1172Multiple drug overdose intentionalFAERS: 1US FAERS
1173Muscle strainFAERS: 1US FAERS
1174Muscle tone disorderFAERS: 1US FAERS
1175MyoglobinuriaFAERS: 1US FAERS
1176MyopericarditisFAERS: 1US FAERS
1177MyopiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1178MyotoniaFAERS: 1US FAERS
1179N-terminal prohormone brain natriuretic peptide increasedFAERS: 1US FAERS
1180Nail pickingFAERS: 1US FAERS
1181Nasopharyngeal refluxFAERS: 1US FAERS
1182Neonatal hypotensionFAERS: 1US FAERS
1183Neonatal pneumoniaFAERS: 1US FAERS
1184Neonatal respiratory arrestFAERS: 1US FAERS
1185NephrectomyFAERS: 1US FAERS
1186NephrocalcinosisFAERS: 1US FAERS
1187NeurodermatitisFAERS: 1US FAERS
1188Neurogenic BowelFAERS: 1US FAERS
1189Neurological examination abnormalFAERS: 1US FAERS
1190Neurological examination normalFAERS: 1US FAERS
1191Neuromyelitis OpticaFAERS: 1US FAERS
1192Neuropsychological test abnormalFAERS: 1US FAERS
1193No reaction on previous exposure to drugFAERS: 1US FAERS
1194NoduleFAERS: 1US FAERS
1195Nonspecific reactionFAERS: 1US FAERS
1196Nuchal RigidityFAERS: 1US FAERS
1197Oculogyric crisisFAERS: 1US FAERS
1198Olfactory Nerve DisorderFAERS: 1US FAERS
1199Oral mucosal exfoliationFAERS: 1US FAERS
1200Oral pruritusFAERS: 1US FAERS
1201Osmotic demyelination syndromeFAERS: 1US FAERS
1202OsteochondrosisFAERS: 1US FAERS
1203Otitis ExternaFAERS: 1US FAERS
1204OtotoxicityFAERS: 1US FAERS
1205PCO2 decreasedFAERS: 1US FAERS
1206PCO2 increasedFAERS: 1US FAERS
1207PO2 increasedFAERS: 1US FAERS
1208PancytopeniaFAERS: 1US FAERS
1209Paranoid Personality DisorderFAERS: 1US FAERS
1210ParaparesisFAERS: 1US FAERS
1211ParasomniaFAERS: 1US FAERS
1212ParotitisFAERS: 1US FAERS
1213Pathogen resistanceFAERS: 1US FAERS
1214Pelvic discomfortFAERS: 1US FAERS
1215Penile blisterFAERS: 1US FAERS
1216Penile burning sensationFAERS: 1US FAERS
1217Penile erythemaFAERS: 1US FAERS
1218Penoscrotal transpositionFAERS: 1US FAERS
1219PeriodontitisFAERS: 1US FAERS
1220Peritonsillar AbscessFAERS: 1US FAERS
1221Persistent left superior vena cavaFAERS: 1US FAERS
1222Personal relationship issueFAERS: 1US FAERS
1223Phalangeal agenesisFAERS: 1US FAERS
1224Pharmaceutical product counterfeitFAERS: 1US FAERS
1225Pharyngolaryngeal PainFAERS: 1US FAERS
1226PhlebitisFAERS: 1US FAERS
1227Phobia of drivingFAERS: 1US FAERS
1228Physical product label issueFAERS: 1US FAERS
1229Platelet aggregation abnormalFAERS: 1US FAERS
1230PoikilocytosisFAERS: 1US FAERS
1231PolyhydramniosFAERS: 1US FAERS
1232Polymyalgia RheumaticaFAERS: 1US FAERS
1233PolyneuropathyFAERS: 1US FAERS
1234Poor feeding infantFAERS: 1US FAERS
1235Portal Vein ThrombosisFAERS: 1US FAERS
1236Post procedural infectionFAERS: 1US FAERS
1237Postoperative infectionFAERS: 1US FAERS
1238Postpericardiotomy SyndromeFAERS: 1US FAERS
1239Potentiating drug interactionFAERS: 1US FAERS
1240Poverty of speechFAERS: 1US FAERS
1241Precancerous skin lesionFAERS: 1US FAERS
1242Pregnancy on oral contraceptiveFAERS: 1US FAERS
1243Pregnancy test positiveFAERS: 1US FAERS
1244Premature MenopauseFAERS: 1US FAERS
1245Premenstrual Dysphoric DisorderFAERS: 1US FAERS
1246PresbyopiaFAERS: 1US FAERS
1247Procedural headacheFAERS: 1US FAERS
1248ProctitisFAERS: 1US FAERS
1249Product contaminationFAERS: 1US FAERS
1250Product contamination microbialFAERS: 1US FAERS
1251Product dosage form confusionFAERS: 1US FAERS
1252Product label issueFAERS: 1US FAERS
1253Product lot number issueFAERS: 1US FAERS
1254Product packaging quantity issueFAERS: 1US FAERS
1255Product preparation errorFAERS: 1US FAERS
1256Product prescribing errorFAERS: 1US FAERS
1257Product use complaintFAERS: 1US FAERS
1258Productive CoughFAERS: 1US FAERS
1259Progesterone increasedFAERS: 1US FAERS
1260Prothrombin level decreasedFAERS: 1US FAERS
1261Psychogenic seizureFAERS: 1US FAERS
1262Psychological TraumaFAERS: 1US FAERS
1263Pulmonary microemboliFAERS: 1US FAERS
1264Pulmonary thrombosisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1265PurpuraFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1266Purulent dischargeFAERS: 1US FAERS
1267PyelocaliectasisFAERS: 1US FAERS
1268PyelonephritisFAERS: 1US FAERS
1269QRS axis abnormalFAERS: 1US FAERS
1270QuadriplegiaFAERS: 1US FAERS
1271Reaction to azo-dyesFAERS: 1US FAERS
1272Refractory cytopenia with unilineage dysplasiaFAERS: 1US FAERS
1273Relapsing FeverFAERS: 1US FAERS
1274Renal Cell CarcinomaFAERS: 1US FAERS
1275Renal ColicFAERS: 1US FAERS
1276Renal fusion anomalyFAERS: 1US FAERS
1277Renal massFAERS: 1US FAERS
1278Renin increasedFAERS: 1US FAERS
1279Respiratory DepressionFAERS: 1US FAERS
1280Respiratory papillomaFAERS: 1US FAERS
1281Restrictive pulmonary diseaseFAERS: 1US FAERS
1282Retinal exudatesFAERS: 1US FAERS
1283RetinitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
1284Reversible cerebral vasoconstriction syndromeFAERS: 1US FAERS
1285Rheumatoid ArthritisFAERS: 1US FAERS
1286RhinitisFAERS: 1US FAERS
1287Right Ventricular DysfunctionFAERS: 1US FAERS
1288SarcoidosisFAERS: 1US FAERS
1289ScabFAERS: 1US FAERS
1290Scan myocardial perfusion abnormalFAERS: 1US FAERS
1291School refusalFAERS: 1US FAERS
1292Seasonal Affective DisorderFAERS: 1US FAERS
1293Secondary hypothyroidismFAERS: 1US FAERS
1294Semen volume decreasedFAERS: 1US FAERS
1295Sensory processing disorderFAERS: 1US FAERS
1296Serum SicknessFAERS: 1US FAERS
1297Sexual relationship changeFAERS: 1US FAERS
1298ShopliftingFAERS: 1US FAERS
1299Shoulder PainFAERS: 1US FAERS
1300Sick Sinus SyndromeFAERS: 1US FAERS
1301Sight disabilityFAERS: 1US FAERS
1302SigmoiditisFAERS: 1US FAERS
1303Skin ErosionFAERS: 1US FAERS
1304Skin discomfortFAERS: 1US FAERS
1305Skin irritationFAERS: 1US FAERS
1306Skin necrosisFAERS: 1US FAERS
1307Sleep inertiaFAERS: 1US FAERS
1308Sleep study abnormalFAERS: 1US FAERS
1309Somatic symptom disorderFAERS: 1US FAERS
1310Spermatozoa progressive motility decreasedFAERS: 1US FAERS
1311Spina Bifida OccultaFAERS: 1US FAERS
1312Spinal column injuryFAERS: 1US FAERS
1313Spinal column stenosisFAERS: 1US FAERS
1314Splenic RuptureFAERS: 1US FAERS
1315Staphylococcal mediastinitisFAERS: 1US FAERS
1316StaringFAERS: 1US FAERS
1317StarvationFAERS: 1US FAERS
1318Status EpilepticusFAERS: 1US FAERS
1319Stem cell transplantFAERS: 1US FAERS
1320Stress at workFAERS: 1US FAERS
1321StridorFAERS: 1US FAERS
1322Subcutaneous AbscessFAERS: 1US FAERS
1323SubileusFAERS: 1US FAERS
1324Sudden onset of sleepFAERS: 1US FAERS
1325Surgical StaplingFAERS: 1US FAERS
1326Swallow study abnormalFAERS: 1US FAERS
1327T-Cell LymphomaFAERS: 1US FAERS
1328Tablet issueFAERS: 1US FAERS
1329Tablet physical issueFAERS: 1US FAERS
1330TachyarrhythmiaFAERS: 1US FAERS
1331TattooFAERS: 1US FAERS
1332Temperature regulation disorderFAERS: 1US FAERS
1333TetanyFAERS: 1US FAERS
1334Therapeutic product effect variableFAERS: 1US FAERS
1335Therapeutic response delayedFAERS: 1US FAERS
1336Therapy cessationFAERS: 1US FAERS
1337Therapy regimen changedFAERS: 1US FAERS
1338Therapy responderFAERS: 1US FAERS
1339Thirst decreasedFAERS: 1US FAERS
1340Thoracic Outlet SyndromeFAERS: 1US FAERS
1341ThrombophlebitisFAERS: 1US FAERS
1342Thrombosis in deviceFAERS: 1US FAERS
1343Tongue discomfortFAERS: 1US FAERS
1344Tongue eruptionFAERS: 1US FAERS
1345Tongue movement disturbanceFAERS: 1US FAERS
1346Tonic clonic movementsFAERS: 1US FAERS
1347TonsillitisFAERS: 1US FAERS
1348Tooth ExtractionFAERS: 1US FAERS
1349Tooth repairFAERS: 1US FAERS
1350ToxoplasmosisFAERS: 1US FAERS
1351TracheitisFAERS: 1US FAERS
1352Transmission of drug via semenFAERS: 1US FAERS
1353Traumatic Brain InjuryFAERS: 1US FAERS
1354TrichorrhexisFAERS: 1US FAERS
1355TrichotillomaniaFAERS: 1US FAERS
1356Trigeminal NeuralgiaFAERS: 1US FAERS
1357Triple vessel bypass graftFAERS: 1US FAERS
1358Trisomy 21FAERS: 1US FAERS
1359TuberculosisFAERS: 1US FAERS
1360Umbilical herniaFAERS: 1US FAERS
1361Unresponsive to pain stimuliFAERS: 1US FAERS
1362Unwanted pregnancyFAERS: 1US FAERS
1363Upper respiratory tract congestionFAERS: 1US FAERS
1364Urinary tract obstructionFAERS: 1US FAERS
1365Urine flow decreasedFAERS: 1US FAERS
1366Uterine contractions during pregnancyFAERS: 1US FAERS
1367Uterine spasmFAERS: 1US FAERS
1368UveitisFAERS: 1US FAERS
1369Vaginal lesionFAERS: 1US FAERS
1370Vaginal mucosal blisteringFAERS: 1US FAERS
1371Vagus Nerve DisorderFAERS: 1US FAERS
1372Vanishing twin syndromeFAERS: 1US FAERS
1373VaricoceleFAERS: 1US FAERS
1374Vascular ruptureFAERS: 1US FAERS
1375Ventricular FibrillationFAERS: 1US FAERS
1376Ventricular FlutterFAERS: 1US FAERS
1377Ventricular hyperkinesiaFAERS: 1US FAERS
1378Viral tonsillitisFAERS: 1US FAERS
1379Viral upper respiratory tract infectionFAERS: 1US FAERS
1380Visual brightnessFAERS: 1US FAERS
1381VitiligoFAERS: 1US FAERS
1382Vulvovaginal mycotic infectionFAERS: 1US FAERS
1383Vulvovaginal painFAERS: 1US FAERS
1384Waist circumference increasedFAERS: 1US FAERS
1385White blood cell morphology abnormalFAERS: 1US FAERS
1386Wolff-Parkinson-White SyndromeFAERS: 1US FAERS
1387Wrong drug administeredFAERS: 1US FAERS
1388Wrong product administeredFAERS: 1US FAERS
1389kyphosisFAERS: 1US FAERS
1390Granulomatous liver diseaseCanada Vigilance: 1Canada Vigilance
1391Nephrotic SyndromeCanada Vigilance: 1Canada Vigilance
1392Orgasmic sensation decreasedCanada Vigilance: 1Canada Vigilance
1393Patient restraintCanada Vigilance: 1Canada Vigilance
1394PseudolymphomaCanada Vigilance: 1Canada Vigilance
1395Retinal Artery OcclusionCanada Vigilance: 1Canada Vigilance
1396Sleep ParalysisCanada Vigilance: 1Canada Vigilance
1397SplenomegalyCanada Vigilance: 1Canada Vigilance
1398Sudden infant death syndromeCanada Vigilance: 1Canada Vigilance
1399Therapeutic product effect decreasedCanada Vigilance: 2Canada Vigilance
1400Therapy changeCanada Vigilance: 1Canada Vigilance
1401Tobacco interactionCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120329

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.